Our mission is to support ALS (Lou Gehrig’s Disease) research and scientific investigations at the Cecil B. Day Laboratory by raising funds through events, campaigns, foundation grants and numerous other community outreach activities, to aid in finding a cause, treatment and cure for ALS.
Our Non-Profit Setup
Our offices are located in the law firm of Nigro Pettipet and Lucas, courtesy of Directors Jan and Eugene Nigro. Angel Fund President Rich Kennedy and the board members are not paid. As a result, it means we have very low overhead and administrative costs so more money goes to research. We are proud to say that 92% of funds expended goes to research.
- No rent
- No utility bills
- No high paid executives
Silencing of an ALS gene safely delivered to patients in UMass Medical School study

By Jim Fessenden, UMass Medical School Communications
UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment, which targeted the mutant SOD1 gene that causes ALS, appear in the New England Journal of Medicine.
Read more.
watch video.